Zacks Initiates Coverage on SolarBank Corp. (NASDAQ: SUUN)

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
113
Zacks Initiates Coverage on SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2)

- Despite policy uncertainty, demand for scalable solar and storage solutions in North America remains strong, especially in commercial and community sectors, the Zacks report says.
- The company has a development pipeline exceeding 1 GW and is aiming to triple its owned capacity in the next two years.
- SolarBank is expanding from solar EPC services into independent power production (“IPP”) and battery energy storage systems (“BESS”).

Disseminated on behalf of SolarBank Corporation

Zacks Small-Cap Research has launched coverage of SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S. (https://nnw.fm/LM9e0 ). The Zacks report highlights SolarBank’s growing role as an integrated energy firm with a strategy focused on building out its independent power production (“IPP”) capabilities and battery energy storage systems (“BESS”) to meet rising electricity demand in North America.

SolarBank is transitioning from an engineering, procurement, and construction (“EPC”) provider to owning and operating more of its own solar and storage assets. This shift is expected to improve revenue consistency and margins over time. The company is currently managing a project pipeline that exceeds 1 gigawatt (“GW”) and has already completed installations totaling more than 200 megawatts (“MW”), according to the Zacks report (https://nnw.fm/IWEwS ).

Currently, SolarBank has approximately 25 MWp of solar and 60 MWh of storage under construction, with another 149 MWp in late-stage development. Over the next 24 months, the company expects to triple its owned solar and storage capacity. This growth is being driven by both private-sector demand and the need for energy systems that can be quickly deployed.

Zacks expects significant revenue growth for SolarBank in FY2025 and FY2026. This projection is supported by contracts with Qcells and Honeywell and an expanding backlog of IPP and BESS projects. The battery energy storage segment, in particular, is emerging as a critical piece of North America’s energy infrastructure. BESS is forecast to be the fastest-growing part of the energy sector through 2030, driven by the electrification of transportation, increasing data center demand, and grid stability needs. SolarBank’s involvement in this space positions it well to benefit from these trends.

Policy risk remains a factor. Although political developments have introduced uncertainty into federal renewable energy policy, potentially affecting incentives and regulatory frameworks, Zacks notes that the practical need for new energy infrastructure—especially in commercial, industrial, and community-scale solar—will likely continue to drive demand regardless of political developments.

SolarBank’s share price has seen volatility in recent months, influenced by macro policy signals and recent below-market financing. However, the Zacks report suggests that the company’s fundamentals and strategic focus could offer upside for investors willing to navigate short-term market noise.

Investors interested in the renewable energy space may find SolarBank’s expanding IPP footprint and BESS focus to be compelling aspects of a longer-term growth story, particularly as utility-scale and commercial solar continue to outpace residential deployment. As the demand for scalable and reliable energy solutions rises, SolarBank’s role as both a developer and operator could position it to deliver more consistent returns in a sector known for volatility.

For more information, visit the company’s website at SolarBankCorp.com.

This report contains forward looking information. Please refer to the press release entitled “SolarBank Announces 2024 Highlights” for additional details on the statements, risks and assumptions. The target price and revenue forecasts in the report are based on Zacks analysis and the company has not provided guidance to Zacks on this matter. While SolarBank paid Zacks a fee to complete the report, the report was based on Zacks analysis.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://nnw.fm/SUUN

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer

SolarBank Corp. (SUUN) Stock Research Links

SUUN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 229

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 308

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 218

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Orion Corporation's Manager Transactions Highlight Executive Moves

Updated Category News Views 133

Understanding Orion Corporation's Executive Transactions Orion Corporation, a prominent player in the global pharmaceutical industry, has recently disclosed significant transactions involving its management, shedding light on financial movements that reflect company growth and strategy. Key Details on Managerial Transactions Recently, Orion Corporation reported under the...

Continue Reading
Congressman Questions SEC's 'Digital Asset Security' Definition

Updated Category News Views 150

Congressman Ritchie Torres Questions SEC's Use of Terminology Representative Ritchie Torres, a Democratic representative from New York, has recently shared his concerns about the phrase "digital asset security" as used by the U.S. Securities and Exchange Commission (SEC). He’s particularly interested in the legal basis and origins of this term. Congressional Dialogue...

Continue Reading
Investigating Claims for StubHub Investors: Your Options

Updated Category News Views 173

Investigation of Claims on Behalf of StubHub Investors Faruqi & Faruqi, LLP, a prominent name in national securities law, is currently looking into potential claims related to StubHub Holdings, Inc. (NYSE: STUB). This initiative aims to assist investors who might have faced losses due to the misleading statements made about the company's financial performance during its...

Continue Reading
Sarepta Therapeutics Faces Class Action Amid Safety Concerns

Updated Category News Views 256

Introduction to Sarepta Therapeutics Sarepta Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, particularly those associated with genetic factors. The company is well-known for its gene therapy treatments and aims to revolutionize treatment options for patients with Duchenne muscular dystrophy and similar...

Continue Reading